Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

Austin RM, Zhao C.

Cytojournal. 2014 May 22;11:14. doi: 10.4103/1742-6413.132997. eCollection 2014. Review.

PMID:
24987445
[PubMed]
Free PMC Article
2.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

PMID:
24762804
[PubMed - in process]
Free Article
3.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969
[PubMed - indexed for MEDLINE]
4.

[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].

Ronco G, Confortini M, Maccallini V, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Giorgi Rossi P.

Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33. Review. Italian.

PMID:
23139163
[PubMed - indexed for MEDLINE]
5.

Anal dysplasia screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(4):1-43. Epub 2007 Jun 1.

PMID:
23074504
[PubMed]
Free PMC Article
6.

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.

Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M, Peto J; ARTISTIC Trial Study Group.

Health Technol Assess. 2009 Nov;13(51):1-150, iii-iv. doi: 10.3310/hta13510.

PMID:
19891902
[PubMed - indexed for MEDLINE]
Free Article
7.

Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet].

Kulasingam SL, Havrilesky L, Ghebre R, Myers ER.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May.

PMID:
22553886
[PubMed]
Books & Documents
8.

Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.

Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.

Acta Cytol. 2012;56(5):506-14. doi: 10.1159/000338979. Epub 2012 Sep 27.

PMID:
23075891
[PubMed - indexed for MEDLINE]
9.

Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.

Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, Pan QJ, Ma JF, Niyazi M, Li CQ, Li SM, Smith JS, Belinson JL, Qiao YL, Castle PE.

J Natl Cancer Inst. 2012 Feb 8;104(3):178-88. doi: 10.1093/jnci/djr532. Epub 2012 Jan 23.

PMID:
22271765
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.

Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU.

Ann Intern Med. 2011 Nov 15;155(10):687-97, W214-5. doi: 10.7326/0003-4819-155-10-201111150-00376. Epub 2011 Oct 17. Review. Erratum in: Ann Intern Med. 2012 Jan 3;156(1 Pt 1):71-2.

PMID:
22006930
[PubMed - indexed for MEDLINE]
11.

Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile.

Ferreccio C, Barriga MI, Lagos M, Ibáñez C, Poggi H, González F, Terrazas S, Katki HA, Núñez F, Cartagena J, Van De Wyngard V, Viñales D, Brañes J.

Int J Cancer. 2013 Feb 15;132(4):916-23. doi: 10.1002/ijc.27662. Epub 2012 Jun 26. Erratum in: Int J Cancer. 2013 Jul 15;133(2):E1.

PMID:
22684726
[PubMed - indexed for MEDLINE]
12.

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.

Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R; PALMS Study Group.

J Natl Cancer Inst. 2013 Oct 16;105(20):1550-7. doi: 10.1093/jnci/djt235. Epub 2013 Oct 4.

PMID:
24096620
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].

Ronco G, Biggeri A, Confortini M, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Accetta G, Giordano L, Cogo C, Carozzi F, Gillio Tos A, Arbyn M, Mejier CJ, Snijders PJ, Cuzick J, Giorgi Rossi P.

Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72. Italian.

PMID:
22828243
[PubMed - indexed for MEDLINE]
14.

Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting.

Hoyer H, Scheungraber C, Kuehne-Heid R, Teller K, Greinke C, Leistritz S, Ludwig B, Dürst M, Schneider A.

Int J Cancer. 2005 Aug 10;116(1):136-43.

PMID:
15756677
[PubMed - indexed for MEDLINE]
15.

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ.

Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Review.

PMID:
18847555
[PubMed - indexed for MEDLINE]
16.

Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India.

Gravitt PE, Paul P, Katki HA, Vendantham H, Ramakrishna G, Sudula M, Kalpana B, Ronnett BM, Vijayaraghavan K, Shah KV; CATCH Study Team.

PLoS One. 2010 Oct 28;5(10):e13711. doi: 10.1371/journal.pone.0013711.

PMID:
21060889
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N; New Technologies for Cervical Cancer Screening Working Group.

J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25.

PMID:
18364502
[PubMed - indexed for MEDLINE]
Free Article
18.

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.

Elfström KM, Smelov V, Johansson AL, Eklund C, Nauclér P, Arnheim-Dahlström L, Dillner J.

BMJ. 2014 Jan 16;348:g130. doi: 10.1136/bmj.g130.

PMID:
24435414
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.

Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M.

Clin Cancer Res. 2012 Aug 1;18(15):4154-62. doi: 10.1158/1078-0432.CCR-12-0270. Epub 2012 Jun 6.

PMID:
22675168
[PubMed - indexed for MEDLINE]
Free Article
20.

Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.

Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, Buckland J, Rydzak G, Lorincz AT, Wacholder S.

J Clin Oncol. 2012 Sep 1;30(25):3044-50. doi: 10.1200/JCO.2011.38.8389. Epub 2012 Jul 30.

PMID:
22851570
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk